Discover Seventure's video
Seventure Partners announces that BPCE invests in its institutional funds, DIGITAL OPPORTUNITIES FUND
Paris, 31st January 2018 – Seventure Partners, a...
Zipongo extends total financing to over $50M to launch FoodScripts™ and lower chronic disease costs
Zipongo plans to use the additional funding to expand...
Seventure Partners Life Sciences Investing Update – H2 2017
“2017 ended on a high note. Our Health For Life...
Vedanta Biosciences announces initiation of Phase 1a/1b trial for new drug class of rationally-defined bacteria consortia derived from the human microbiome
VE303 is first known rationally-defined bacterial...
Vedanta Biosciences Expands Network of Clinical Collaborations Supporting Development of Microbiome Therapeutics for Cancer Immunotherapy
New collaborations with Leiden University Medical Center...
Microbiome Drug Development Summit – Paris, 29-31 January
Come & meet us !
Seventure at the Paris Fintech Forum 30 & 31 January 2018
Come and meet us !
Next Gen Immunology – Rehovot (Israel), 14-16 February
5th Microbiome R&D and Business Collaboration Forum: Europe – Rotterdam, 21-22 March